Relationship Between Hyperventilation Syndrome and SARS-CoV-2 Infection
NCT ID: NCT05224830
Last Updated: 2022-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2846 participants
OBSERVATIONAL
2021-01-01
2022-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19
NCT04370249
Use of Ultrasound for Early Identification of Patients at Risk of Swallowing Disorders Acquired in the ICU
NCT05922085
Hemodynamic Characteristics of Patients With SARS-CoV-2
NCT04337983
COVID-19 : Transcutaneous pO2 and pCO2 as Predictive Factors for Acute Respiratory Destress Syndrome in Patients Affected With SARS-Cov-2
NCT04524156
Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status
NCT04556513
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Presence of Hyperventilation Syndrome (HVS+)
Study population was divided into two groups according to the diagnosis of Hyperventilation Syndrome HVS +- : Nijmegen questionnaire score \> 23/64
Nijmegen questionnaire score
We collected the Nijmegen Questionnaire in order to diagnosis of Hyperventilation Syndrome
No presence of Hyperventilation Syndrome (HVS-).
Study population was divided into two groups according to the diagnosis of Hyperventilation Syndrome HVS - : Nijmegen questionnaire score \< 24/64
Nijmegen questionnaire score
We collected the Nijmegen Questionnaire in order to diagnosis of Hyperventilation Syndrome
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nijmegen questionnaire score
We collected the Nijmegen Questionnaire in order to diagnosis of Hyperventilation Syndrome
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Perform a pulmonary function test
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Régional Universitaire de Nancy.
Vandœuvre-lès-Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021PI224-203
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.